Lv1
28 积分 2025-06-19 加入
Atrioventricular Coupling Index: A Novel Approach to Risk‐Stratification for Major Adverse Cardiovascular Events in Patients With ST‐Elevation Myocardial Infarction
5个月前
已完结
Left atrial strain by reperfusion strategy as a predictor for MACE in patients after ST-elevation myocardial infarction
5个月前
已关闭
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multi-Domain, Patient-Level Analysis of the MAPLE-HCM Trial
6个月前
已关闭
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
6个月前
已完结
Cardiac morphologic and functional characteristics in patients with left ventricular excessive Trabeculation versus apical hypertrophic cardiomyopathy
6个月前
已关闭
The Revolution of Cardiac Myosin Inhibitors in Patients With Hypertrophic Cardiomyopathy
6个月前
已完结
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
6个月前
已完结
Real-world outcomes of mavacamten for symptomatic obstructive hypertrophic cardiomyopathy: global evidence from COLLIGO-HCM
7个月前
已关闭
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
7个月前
已完结
Can Vulnerable Plaque Imaging PREVENT Cardiovascular Events?
7个月前
已完结
皖公网安备34019202002308
